153 related articles for article (PubMed ID: 15004125)
1. Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole.
Lodge BA; Ashley ED; Steele MP; Perfect JR
J Clin Microbiol; 2004 Mar; 42(3):1376-8. PubMed ID: 15004125
[TBL] [Abstract][Full Text] [Related]
2. Duration of posaconazole therapy for Aspergillus fumigatus osteomyelitis dictated by serial monitoring of 1,3-beta-D glucan.
Doub JB; Mathur P
Infection; 2020 Dec; 48(6):959-963. PubMed ID: 32720130
[TBL] [Abstract][Full Text] [Related]
3. [Aspergillus tracheobronchitis in a lung transplant recipient].
García-Gallo CL; García-Fadul C; Laporta-Hernández R; Ussetti-Gil P
Rev Iberoam Micol; 2011; 28(3):129-33. PubMed ID: 21700233
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous aspergillosis in a lung transplant recipient.
Ramos A; Ussetti P; Laporta R; Lázaro MT; Sánchez-Romero I
Transpl Infect Dis; 2009 Oct; 11(5):471-3. PubMed ID: 19622116
[TBL] [Abstract][Full Text] [Related]
5. Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole.
Kuipers S; Brüggemann RJ; de Sévaux RG; Heesakkers JP; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2011 Jul; 55(7):3564-6. PubMed ID: 21502625
[TBL] [Abstract][Full Text] [Related]
6. Treatment of
Shearin S; Bell T
Am J Health Syst Pharm; 2018 Jul; 75(13):958-961. PubMed ID: 29941535
[TBL] [Abstract][Full Text] [Related]
7. Invasive aspergillosis with polyarthritis.
Mekan SF; Saeed O; Khan JA
Mycoses; 2004 Dec; 47(11-12):518-20. PubMed ID: 15601460
[TBL] [Abstract][Full Text] [Related]
8. Septic arthritis due to Aspergillus treated with amphotericin B lipid complex and surgical debridement.
Saba R; Beköz H; Karadoğan I; Inan D; Bilgin-Uğur A; Oğünç D; Cevikol C; Temizkan K; Timurağaoğlu A; Undar L
J Chemother; 2004 Apr; 16(2):218-20. PubMed ID: 15216961
[No Abstract] [Full Text] [Related]
9. Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.
Jeong W; Snell GI; Levvey BJ; Westall GP; Morrissey CO; Ivulich S; Neoh CF; Slavin MA; Kong DCM
J Antimicrob Chemother; 2017 Jul; 72(7):2089-2092. PubMed ID: 28369489
[TBL] [Abstract][Full Text] [Related]
10. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
11. Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
Wéclawiak H; Garrouste C; Kamar N; Linas MD; Tall P; Dambrin C; Durand D; Rostaing L
Transplant Proc; 2007 Oct; 39(8):2627-8. PubMed ID: 17954195
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of posaconazole in a murine model of central nervous system aspergillosis.
Imai JK; Singh G; Clemons KV; Stevens DA
Antimicrob Agents Chemother; 2004 Oct; 48(10):4063-6. PubMed ID: 15388482
[TBL] [Abstract][Full Text] [Related]
13. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery.
Hodiamont CJ; Dolman KM; Ten Berge IJ; Melchers WJ; Verweij PE; Pajkrt D
Med Mycol; 2009 Mar; 47(2):217-20. PubMed ID: 19101840
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
15. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
Kiyokawa H; Nakashima R; Takafuji S; Suzuki Y; Ito A
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):448-54. PubMed ID: 18592989
[TBL] [Abstract][Full Text] [Related]
16. Aspergillus fumigatus spondylodiskitis in renal transplant patient: voriconazole experience.
Ersoy A; Dizdar OS; Koc AO; Akalin H; Ener B
Exp Clin Transplant; 2011 Aug; 9(4):265-9. PubMed ID: 21819372
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of Aspergillus empyema using combined intrathoracic and intravenous administration of voriconazole: A case report.
Takatsuka H; Yamazaki S; Watanabe A; Yokoyama I; Suzuki T; Kamei K; Ishii I
J Infect Chemother; 2020 Aug; 26(8):847-850. PubMed ID: 32414688
[TBL] [Abstract][Full Text] [Related]
19. Use of posaconazole in the management of invasive orbital aspergillosis in a cat.
McLellan GJ; Aquino SM; Mason DR; Kinyon JM; Myers RK
J Am Anim Hosp Assoc; 2006; 42(4):302-7. PubMed ID: 16822770
[TBL] [Abstract][Full Text] [Related]
20. Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
Al-Tawfiq JA; Al-Abdely HM
Med Mycol; 2010 May; 48(3):537-41. PubMed ID: 19886765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
